933.3000 1.25 (0.13%)
NSE Oct 06, 2025 15:31 PM
Volume: 96,457
 

933.30
0.13%
BOB Capital Markets Ltd.
Q2 revenue in line at Rs 6bn but EBITDA/PAT 3%/6% below our estimates due to higher opex and a product mix change
Alivus Life Sciences.. has an average target of 1317.00 from 1 broker.
More from Alivus Life Sciences Ltd.
Recommended